GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $4.305B (100.0% shares, 0.0% debt)

Holdings (22)

DLO DLOCAL 21.8%

Value $939M Shares 63,906,695 Est. Cost — Unrealized —

XP XP, INC 17.7%

Value $760M Shares 29,617,733 Est. Cost — Unrealized —

ALKT ALKAMI 10.7%

Value $460M Shares 18,729,806 Est. Cost — Unrealized —

— HIRERIGHT 10.6%

Value $458M Shares 32,109,898 Est. Cost — Unrealized —

— SQUARESPACE 9.0%

Value $387M Shares 10,611,073 Est. Cost — Unrealized —

ALHC ALIGNMENT HEALTHCARE 7.0%

Value $303M Shares 60,993,323 Est. Cost — Unrealized —

PHVS PHARVARIS 4.0%

Value $174M Shares 7,531,252 Est. Cost — Unrealized —

EWCZ EUROPEAN WAX CENTER 4.0%

Value $170M Shares 13,110,492 Est. Cost — Unrealized —

— AKERO THERAPEUTICS 3.1%

Value $132M Shares 5,233,989 Est. Cost — Unrealized —

CNTA CENTESSA PHARMACEUTICALS 2.5%

Value $109M Shares 9,681,818 Est. Cost — Unrealized —

IMCR IMMUNOCORE 2.3%

Value $97.93M Shares 1,506,684 Est. Cost — Unrealized —

HCM HUTCHMED 1.6%

Value $67.2M Shares 4,000,000 Est. Cost — Unrealized —

BLND BLEND LABS 1.4%

Value $62.18M Shares 19,132,440 Est. Cost — Unrealized —

RPRX ROYALTY PHARMA 1.1%

Value $45.55M Shares 1,500,000 Est. Cost — Unrealized —

MBLY MOBILEYE 0.9%

Value $38.41M Shares 1,194,839 Est. Cost — Unrealized —

RSKD RISKIFIED 0.7%

Value $28.81M Shares 5,324,998 Est. Cost — Unrealized —

— THIRD HARMONIC BIO 0.6%

Value $27.93M Shares 2,958,762 Est. Cost — Unrealized —

— ACELYRIN 0.5%

Value $19.51M Shares 2,889,668 Est. Cost — Unrealized —

OPEN OPENDOOR 0.4%

Value $19.15M Shares 6,321,519 Est. Cost — Unrealized —

Value $3.469M Shares 609,616 Est. Cost — Unrealized —

GROV GROVE COLLABORATIVE 0.0%

Value $1.563M Shares 936,020 Est. Cost — Unrealized —

ADAG ADAGENE 0.0%

Value $739K Shares 264,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DLO	DLOCAL	63,906,695	$939M	21.8%	—	—	CL A	G29018101
XP	XP, INC	29,617,733	$760M	17.7%	—	—	CL A	G98239109
ALKT	ALKAMI	18,729,806	$460M	10.7%	—	—	COM	01644J108
—	HIRERIGHT	32,109,898	$458M	10.6%	—	—	COM	433537107
—	SQUARESPACE	10,611,073	$387M	9.0%	—	—	CL A	85225A107
ALHC	ALIGNMENT HEALTHCARE	60,993,323	$303M	7.0%	—	—	COM	01625V104
PHVS	PHARVARIS	7,531,252	$174M	4.0%	—	—	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$170M	4.0%	—	—	CL A	29882P106
—	AKERO THERAPEUTICS	5,233,989	$132M	3.1%	—	—	COM	00973Y108
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$109M	2.5%	—	—	ADR	152309100
IMCR	IMMUNOCORE	1,506,684	$97.93M	2.3%	—	—	ADS	45258D105
HCM	HUTCHMED	4,000,000	$67.2M	1.6%	—	—	ADS	44842L103
BLND	BLEND LABS	19,132,440	$62.18M	1.4%	—	—	CL A	09352U108
RPRX	ROYALTY PHARMA	1,500,000	$45.55M	1.1%	—	—	SHS CLASS A	G7709Q104
MBLY	MOBILEYE	1,194,839	$38.41M	0.9%	—	—	CL A	60741F104
RSKD	RISKIFIED	5,324,998	$28.81M	0.7%	—	—	CL A	M8216R109
—	THIRD HARMONIC BIO	2,958,762	$27.93M	0.6%	—	—	COM	88427A107
—	ACELYRIN	2,889,668	$19.51M	0.5%	—	—	ORD	00445A100
OPEN	OPENDOOR	6,321,519	$19.15M	0.4%	—	—	COM	683712103
—	WISH	609,616	$3.469M	0.1%	—	—	CL A	21077C305
GROV	GROVE COLLABORATIVE	936,020	$1.563M	0.0%	—	—	CL A	39957D201
ADAG	ADAGENE	264,000	$739K	0.0%	—	—	ADR	005329107